ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2013 | $372,000 | – | 22,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 1,067,892 | $120,640,000 | 41.48% |
Palo Alto Investors LP | 2,187,242 | $247,093,000 | 13.75% |
VHCP Management, LLC | 140,756 | $15,901,000 | 9.61% |
HWG Holdings LP | 48,910 | $5,525,000 | 5.62% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 906,287 | $102,383,000 | 4.98% |
Baker Brothers Advisors | 4,198,520 | $474,307,000 | 3.93% |
Asymmetry Capital Management, L.P. | 15,591 | $1,761,000 | 2.66% |
NEXT CENTURY GROWTH INVESTORS LLC | 496,744 | $56,117,000 | 2.42% |
AlpInvest Partners B.V. | 11,551 | $1,305,000 | 2.17% |
Atika Capital Management LLC | 36,000 | $4,067,000 | 2.09% |